More articles from Medical Grand Rounds

  • Beta2-microglobulin amyloidosis in renal failure: Understanding this recently recognized condition
    Jonathan Kay, MD
    Cleveland Clinic Journal of Medicine March 1999, 66 (3) 145-147;

    Most long-term dialysis patients eventually acquire amyloid deposits, with resultant musculoskeletal problems. Yet, the condition was recognized only recently.

  • Thalidomide’s tightly controlled “comeback”
    Leonard H. Calabrese, DO
    Cleveland Clinic Journal of Medicine March 1999, 66 (3) 136-138;

    A drug that was banned 40 years ago because of its potential for causing serious birth defects has found new uses—with strict safeguards.

  • Is stress linked to heart disease?
    Fredric J. Pashkow, MD
    Cleveland Clinic Journal of Medicine February 1999, 66 (2) 75-77;

    Recent evidence confirms the popular folklore that mental stress has harmful effects on coronary health. Stress management programs are beneficial in coronary rehabilitation.

  • New technology and new challenges for assisted reproduction
    Tommaso Falcone, MD
    Cleveland Clinic Journal of Medicine February 1999, 66 (2) 78-82;

    With advances in the science of reproduction come more options, and more ethical dilemmas.

  • Deep brain stimulation reduces symptoms of Parkinson disease
    Erwin B. Montgomery, MD
    Cleveland Clinic Journal of Medicine January 1999, 66 (1) 9-11;

    When medications fail to control the symptoms of Parkinson disease, either surgery or a small implanted electrical device can help. With an illustration of how deep brain stimulation works.

  • Idiopathic thrombocytopenic purpura: Guidance amid uncertainty
    Alan Lichtin, MD
    Cleveland Clinic Journal of Medicine November 1998, 65 (10) 510-514;

    A panel of experts has issued clinical guidelines for treating thrombocytopenic purpura, but points out that we lack solid evidence from randomized trials.

  • The keyhole or the manhole? What internists need to know about minimally invasive CABG
    Joseph Sabik, MD
    Cleveland Clinic Journal of Medicine October 1998, 65 (9) 454-456;

    Thousands of patients have undergone minimally invasive coronary artery bypass surgery, but some have contraindications to it. With an illustration showing the two major minimally invasive techniques.

  • The prostate cancer screening controversy in perspective
    Kenneth W. Vaughn, MD
    Cleveland Clinic Journal of Medicine October 1998, 65 (9) 459-462;

    The value of screening for prostate cancer is not yet proven, hut the magnitude of the problem argues for action.

  • Ultrasound and alendronate: New tools for osteoporosis screening and treatment
    Richard P. Tonino, MD
    Cleveland Clinic Journal of Medicine September 1998, 65 (8) 398-401;

    Ultrasound should make osteoporosis easier to diagnose, and alendronate should make it easier to treat.

  • New options for diagnosing and treating acromegaly
    Ariel L. Barkan, MD
    Cleveland Clinic Journal of Medicine July 1998, 65 (7) 343-349;

    Insulin-like growth factor 1 (IGF-1) is a more sensitive clinical marker of acromegaly than growth hormone. Two new somatostatin analogs are available for treatment. With an illustration explaining the growth hormone cascade.

Pages